Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality

被引:3
|
作者
Na, Hee Young [1 ]
Kim, Jee Hyun [2 ]
Kim, Haeryoung [3 ]
Cho, Jai Young [4 ]
Han, Ho-Seong [4 ]
Jang, Eun Sun [5 ]
Kim, Jin-Wook [5 ]
Jeong, Sook-Hyang [5 ]
Heo, Jayoon [2 ,6 ]
Kim, Ji-Won [2 ]
Kim, Jin Won [2 ]
Ahn, Soomin [1 ,7 ,8 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Coll Med, Seongnam, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Hematol & Med Oncol,Bundang Hosp, Seongnam, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul Natl Univ Hosp, Seoul, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Surg, Seongnam, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Bundang Hosp, Seongnam, South Korea
[6] Ilsan Hosp, Dept Internal Med, Natl Hlth Insurance Serv, Goyang, South Korea
[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[8] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol & Translat Genom, Sch Med, 81 Irwon ro, Seoul 06351, South Korea
关键词
combined hepatocellular-cholangiocarcinoma; intermediate cell carcinoma; liver; next-generation sequencing; CARCINOMA;
D O I
10.1111/his.15081
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of liver tumour that exhibits both hepatocytic and biliary differentiation within the same tumour. The histology and genomic alterations of recurrent/metastatic cHCC-CC are poorly understood. We selected six patients with cHCC-CC whose recurrent or metastatic tumours were histologically confirmed. Four patients with classic cHCC-CCs and two with intermediate cell carcinomas (ICs) were included. The clinicopathological features were evaluated, and next-generation sequencing was performed in 17 multiregional and longitudinal tumour samples. The histology of recurrent/metastatic lesions of classic cHCC-CCs was variable: hepatocellular carcinoma (HCC) was observed in one (25.0%) patient, cHCC-CC in one (25.0%) patient, and cholangiocarcinoma (CC) in two (50.0%) patients. Among 13 samples from four classic cHCC-CC patients, the most frequent pathological variants were TP53 (46.2%), TERT promoter (38.5%), ARID1A mutations (23.1%), and MET amplification (30.8%). In the sequencing analysis of each HCC and CC component, three (75.0%) of the four classic cHCC-CCs shared pathogenic variants. A large proportion of mutations, both pathogenic and those of undetermined significance, were shared by each HCC and CC component. Regarding ICs, the ATM mutation was detected in one patient. In conclusion, the histology of recurrent/metastatic cHCC-CCs was heterogeneous. Genomic profiling of classic cHCC-CCs revealed similar genomic alterations to those of HCC. Considerable overlapping genomic alterations in each HCC and CC component were observed, suggesting a monoclonal origin. Genetic alterations in ICs were different from those in either HCC or CC, suggesting the distinct nature of this tumour. The histology of recurrent/metastatic tumours of cHCC-CCs was variable. Genomic profiling of cHCC-CC revealed considerable overlapping genomic alterations in each HCC and CC component.image
引用
收藏
页码:402 / 408
页数:7
相关论文
共 50 条
  • [41] Treating an Advanced Combined Hepatocellular-Cholangiocarcinoma with a Multikinase Inhibitor
    Fraga, Teresa
    Bonito, Nuno
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [42] Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma
    Loosen, SvenH.
    Gaisa, NadineT.
    Schmeding, Maximilian
    Heining, Christoph
    Uhrig, Sebastian
    Wirtz, TheresaH.
    Kalverkamp, Sebastian
    Spillner, Jan
    Tacke, Frank
    Stenzinger, Albrecht
    Glimm, Hanno
    Froehling, Stefan
    Trautwein, Christian
    Roderburg, Christoph
    Longerich, Thomas
    Neumann, UlfPeter
    Luedde, Tom
    CASE REPORTS IN GASTROENTEROLOGY, 2020, 14 (03) : 658 - 667
  • [43] Combined Hepatocellular-Cholangiocarcinoma in a Yellow-Headed Amazon (Amazona oratrix)
    Tennakoon, Anusha Hemamali
    Izawa, Takeshi
    Fujita, Daisuke
    Denda, Yuki
    Seto, Eiko
    Sasai, Hiroshi
    Kuwamura, Mitsuru
    Yamate, Jyoji
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2013, 75 (11): : 1507 - 1510
  • [44] Prognostic Evaluation and Survival Prediction for Combined Hepatocellular-Cholangiocarcinoma Following Hepatectomy
    Chun, Seok-Joo
    Jung, Yu Jung
    Choi, Youngrok
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    Lee, Kyoung Bun
    Kang, Hyun-Cheol
    Chie, Eui Kyu
    Kim, Kyung Su
    CANCER RESEARCH AND TREATMENT, 2025, 57 (01): : 229 - 239
  • [45] Primary Combined Hepatocellular-Cholangiocarcinoma: A Case of Underdiagnosed Primary Liver Cancer
    Ayas, Mohamad F.
    Affas, Saif
    Ayas, Zayd
    Chand, Momal
    Hadid, Tarik
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [46] Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinoma
    Deiana, Chiara
    Palloni, Andrea
    Mosca, Mirta
    Vasuri, Francesco
    Chillotti, Stefano
    Tavolari, Simona
    de Biase, Dario
    Frega, Giorgio
    Giovannetti, Elisa
    Brandi, Giovanni
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [47] Diagnostic value of CEUS LI-RADS and serum tumor markers for combined hepatocellular-cholangiocarcinoma
    Wen, Rong
    Lin, Peng
    Wu, Yuquan
    Yin, Haihui
    Huang, Weiche
    Guo, Danxia
    Peng, Yuye
    Liu, Dun
    He, Yun
    Yang, Hong
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 154
  • [48] Morphomolecular Pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma
    Guest, Rachel, V
    Goeppert, Benjamin
    Nault, Jean-Charles
    Sia, Daniela
    AMERICAN JOURNAL OF PATHOLOGY, 2025, 195 (03): : 345 - 361
  • [49] Imaging features predict prognosis of patients with combined hepatocellular-cholangiocarcinoma
    Mao, Y.
    Xu, S.
    Hu, W.
    Huang, J.
    Wang, J.
    Zhang, R.
    Li, S.
    CLINICAL RADIOLOGY, 2017, 72 (02) : 129 - 135
  • [50] Evaluation of combined hepatocellular-cholangiocarcinoma using CEUS LI-RADS: correlation with pathological characteristics
    Bao, Jingwen
    Nie, Zehua
    Wang, Quanwen
    Chen, Yanling
    Wang, Kun
    Liu, Xinjiang
    ABDOMINAL RADIOLOGY, 2025, 50 (02) : 646 - 655